Skip to main content
Erschienen in: Annals of Surgical Oncology 5/2011

01.05.2011 | Thoracic Oncology

Factors Associated with Postoperative Pulmonary Morbidity After Esophagectomy for Cancer

Erschienen in: Annals of Surgical Oncology | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Most studies analyzing risk factors for pulmonary morbidity date from the early 1990s. Changes in technology and treatment such as minimally invasive esophagectomy (MIE) and neoadjuvant treatment mandate analysis of more contemporary cohorts.

Methods

Predictive factors for overall and specific pulmonary morbidity in 858 patients undergoing esophagectomy between 1998 and 2008 in five Australian university hospitals were analyzed by logistic regression models.

Results

A total of 394 patients underwent open esophagectomy, and 464 patients underwent MIE. A total of 259 patients received neoadjuvant chemoradiotherapy, 139 preoperative chemotherapy alone, and 2 preoperative radiotherapy alone. In-hospital mortality was 3.5%. Smoking and the number of comorbidities were risk factors for overall pulmonary morbidity (odds ratio [OR] 1.47, P = 0.016; OR 1.35, P = 0.001) and pneumonia (OR 2.29, P = 0.002; 1.56, P = 0.005). The risk of respiratory failure was higher in patients with more comorbidities (OR 1.4, P = 0.035). Respiratory comorbidities (OR 3.81, P = 0.017) were strongly predictive of postoperative acute respiratory distress syndrome (ARDS). ARDS (4.51, P = 0.032) or respiratory failure (OR 8.7, P < 0.001), but not anastomotic leak (OR 2.22, P = 0.074), were independent risk factors for death. MIE (OR 0.11, P < 0.001) and thoracic epidural analgesia (OR 0.12, P = 0.003) decreased the risk of respiratory failure. Neoadjuvant treatment was not associated with an increased risk of pulmonary complications.

Conclusions

Preoperative comorbidity and smoking were risk factors for respiratory complications, whereas neoadjuvant treatment was not. MIE and the use of thoracic epidural analgesia decreased the risk of respiratory failure. Respiratory failure and ARDS were the only independent factors associated with an increased risk of in-hospital death, whereas anastomotic leakage was not.
Literatur
1.
Zurück zum Zitat McCulloch P, Ward J, Tekkis PP, for the ASCOT Group of Surgeons. Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BJM. 2003;327:1192–7.CrossRef McCulloch P, Ward J, Tekkis PP, for the ASCOT Group of Surgeons. Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BJM. 2003;327:1192–7.CrossRef
2.
Zurück zum Zitat Avendano CE, Flume PE, Silvestri GA, King LB, Reed CE. Pulmonary complications after esophagectomy. Ann Thorac Surg. 2002;73:922–6.PubMedCrossRef Avendano CE, Flume PE, Silvestri GA, King LB, Reed CE. Pulmonary complications after esophagectomy. Ann Thorac Surg. 2002;73:922–6.PubMedCrossRef
3.
Zurück zum Zitat Ferguson MK, Durkin AE. Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg. 2001;123:661–8.CrossRef Ferguson MK, Durkin AE. Preoperative prediction of the risk of pulmonary complications after esophagectomy for cancer. J Thorac Cardiovasc Surg. 2001;123:661–8.CrossRef
4.
Zurück zum Zitat Law S, Wong K, Kwok K, Chu K, Wong J. Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg. 2004;240:791–800.PubMedCrossRef Law S, Wong K, Kwok K, Chu K, Wong J. Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg. 2004;240:791–800.PubMedCrossRef
5.
Zurück zum Zitat Michelet P, D’Journo XB, Roch A, et al. Protective ventilation influences systemic inflammation after esophagectomy. Anesthesiology. 2006, 105:911–9.PubMedCrossRef Michelet P, D’Journo XB, Roch A, et al. Protective ventilation influences systemic inflammation after esophagectomy. Anesthesiology. 2006, 105:911–9.PubMedCrossRef
6.
Zurück zum Zitat Buise M, van Bommel J, van Genderen M, Tilanus H, van Zundert A, Gommers D. Two-lung high-frequency jet ventilation as an alternative ventilation technique during transthoracic esophagectomy. J Cardiothorac Vasc Anesth. 2009:23:509–12.PubMedCrossRef Buise M, van Bommel J, van Genderen M, Tilanus H, van Zundert A, Gommers D. Two-lung high-frequency jet ventilation as an alternative ventilation technique during transthoracic esophagectomy. J Cardiothorac Vasc Anesth. 2009:23:509–12.PubMedCrossRef
7.
Zurück zum Zitat Smithers BM, Gotley DC, Martin I, Thomas JM. Comparison of the outcomes between open and minimally invasive esophagectomy. Ann Surg. 2007:245:232–40.PubMedCrossRef Smithers BM, Gotley DC, Martin I, Thomas JM. Comparison of the outcomes between open and minimally invasive esophagectomy. Ann Surg. 2007:245:232–40.PubMedCrossRef
8.
Zurück zum Zitat Rigg JRA, Jamrozik K, Myles PS, et al. Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet. 2002;359:1276–82.PubMedCrossRef Rigg JRA, Jamrozik K, Myles PS, et al. Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet. 2002;359:1276–82.PubMedCrossRef
9.
Zurück zum Zitat Tandon S, Batchelor A, Bullock R, et al. Peri-operative risk factors for acute lung injury after elective oesophagectomy. Br J Anaesth. 2001;86:633–8.PubMedCrossRef Tandon S, Batchelor A, Bullock R, et al. Peri-operative risk factors for acute lung injury after elective oesophagectomy. Br J Anaesth. 2001;86:633–8.PubMedCrossRef
10.
Zurück zum Zitat Zingg U, McQuinn A, DiValentino D, et al. Minimally invasive versus open esophagectomy for patients with esophageal cancer. Ann Thorac Surg. 2009;87:911–9.PubMedCrossRef Zingg U, McQuinn A, DiValentino D, et al. Minimally invasive versus open esophagectomy for patients with esophageal cancer. Ann Thorac Surg. 2009;87:911–9.PubMedCrossRef
11.
Zurück zum Zitat Verhage RJ, Hazebroek EJ, Boone J, van Hillegersberg R. Minimally invasive surgey compared to open procedures in esophagectomy for cancer: a systematic review of the literature. Minerva Chir. 2009;64:135–46.PubMed Verhage RJ, Hazebroek EJ, Boone J, van Hillegersberg R. Minimally invasive surgey compared to open procedures in esophagectomy for cancer: a systematic review of the literature. Minerva Chir. 2009;64:135–46.PubMed
12.
Zurück zum Zitat Mariette C, Piessen G, Lamblin A, et al. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma. Br J Surg. 2006;93:1077–83.PubMedCrossRef Mariette C, Piessen G, Lamblin A, et al. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma. Br J Surg. 2006;93:1077–83.PubMedCrossRef
13.
Zurück zum Zitat Bosset J, Gignoux M, Triboulet J, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 1997;337:161–7.PubMedCrossRef Bosset J, Gignoux M, Triboulet J, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 1997;337:161–7.PubMedCrossRef
14.
Zurück zum Zitat Ruol A, Portale G, Castoro C, et al. Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancer. Ann Surg Oncol. 2007;14:3243–50.PubMedCrossRef Ruol A, Portale G, Castoro C, et al. Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancer. Ann Surg Oncol. 2007;14:3243–50.PubMedCrossRef
15.
Zurück zum Zitat Bernard GR, Artigas A, Brigham KL, et al. The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818–24.PubMed Bernard GR, Artigas A, Brigham KL, et al. The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818–24.PubMed
16.
Zurück zum Zitat Martin DJ, Bessell JR, Chew A, Watson DI. Thoracoscopic and laparoscopic esophagectomy. Surg Endosc. 2005;19:1597–601.PubMedCrossRef Martin DJ, Bessell JR, Chew A, Watson DI. Thoracoscopic and laparoscopic esophagectomy. Surg Endosc. 2005;19:1597–601.PubMedCrossRef
17.
Zurück zum Zitat Smithers BM, Gotley DC, McEwan D, et al. Thoracoscopic mobilisation of the esophagus. A 6-year experience. Surg Endosc. 2001;15:176–82.PubMedCrossRef Smithers BM, Gotley DC, McEwan D, et al. Thoracoscopic mobilisation of the esophagus. A 6-year experience. Surg Endosc. 2001;15:176–82.PubMedCrossRef
18.
Zurück zum Zitat Baigrie RJ, Watson DI, Devitt PG, Jamieson GG. Synchronous combined oesophagectomy in the “French” position. Dis Esophagus. 1996;9:226–7. Baigrie RJ, Watson DI, Devitt PG, Jamieson GG. Synchronous combined oesophagectomy in the “French” position. Dis Esophagus. 1996;9:226–7.
19.
Zurück zum Zitat Nakamura M, Iwahashi M, Nakamura M, et al. An analysis of the factors contributing to a reduction in the incidence of pulmonary complications following an esophagectomy for esophageal cancer. Langenbecks Arch Surg. 2008;393:127–33.PubMedCrossRef Nakamura M, Iwahashi M, Nakamura M, et al. An analysis of the factors contributing to a reduction in the incidence of pulmonary complications following an esophagectomy for esophageal cancer. Langenbecks Arch Surg. 2008;393:127–33.PubMedCrossRef
20.
Zurück zum Zitat Sauvanet A, Mariette C, Thomas P, et al. Mortality and morbidity after resection for adenocarcinoma of the gastrointestinal junction: predictive factors. J Am Coll Surg. 2005;201:253–62.PubMedCrossRef Sauvanet A, Mariette C, Thomas P, et al. Mortality and morbidity after resection for adenocarcinoma of the gastrointestinal junction: predictive factors. J Am Coll Surg. 2005;201:253–62.PubMedCrossRef
21.
Zurück zum Zitat Whooley BP, Law S, Murthy SC, Alexandrou A, Wong J. Analysis of reduced death and complication rates after esophageal resection. Ann Surg. 2001;233:338–44.PubMedCrossRef Whooley BP, Law S, Murthy SC, Alexandrou A, Wong J. Analysis of reduced death and complication rates after esophageal resection. Ann Surg. 2001;233:338–44.PubMedCrossRef
22.
Zurück zum Zitat Ruol A, Castoro C, Portale G, et al. Trends in management and prognosis for esophageal cancer surgery. Arch Surg. 2009;144:247–54.PubMedCrossRef Ruol A, Castoro C, Portale G, et al. Trends in management and prognosis for esophageal cancer surgery. Arch Surg. 2009;144:247–54.PubMedCrossRef
23.
Zurück zum Zitat Swisher SG, Deford L, Merriman KW, et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg. 2000;119:1126–32.PubMedCrossRef Swisher SG, Deford L, Merriman KW, et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg. 2000;119:1126–32.PubMedCrossRef
24.
Zurück zum Zitat Luketich JD, Alvelo-Rivera M, Buenaventura P, et al. Minimally invasive esophagectomy. Outcomes in 222 patients. Ann Surg. 2003;238:486–95.PubMed Luketich JD, Alvelo-Rivera M, Buenaventura P, et al. Minimally invasive esophagectomy. Outcomes in 222 patients. Ann Surg. 2003;238:486–95.PubMed
25.
Zurück zum Zitat Joshi GP, Bonnnet F, Shah R, et al. A systematic review of randomized trials evaluating regional techniques for postthoracotomy analgesia. Anesth Analg. 2008;107:1026–40.PubMedCrossRef Joshi GP, Bonnnet F, Shah R, et al. A systematic review of randomized trials evaluating regional techniques for postthoracotomy analgesia. Anesth Analg. 2008;107:1026–40.PubMedCrossRef
26.
Zurück zum Zitat Kelley ST, Coppola D, Karl RC. Neoadjuvant treatment chemoradiotherapy is not associated with a higher complication rate vs. surgery alone in patients undergoing esophagectomy. J Gastrointest Surg. 2004;8:227–32.PubMedCrossRef Kelley ST, Coppola D, Karl RC. Neoadjuvant treatment chemoradiotherapy is not associated with a higher complication rate vs. surgery alone in patients undergoing esophagectomy. J Gastrointest Surg. 2004;8:227–32.PubMedCrossRef
27.
Zurück zum Zitat Lin FC, Durkin AE, Ferguson MK. Induction therapy does not increase surgical morbidity after esophagectomy for cancer. Ann Thorac Surg. 2004;78:1783–9.PubMedCrossRef Lin FC, Durkin AE, Ferguson MK. Induction therapy does not increase surgical morbidity after esophagectomy for cancer. Ann Thorac Surg. 2004;78:1783–9.PubMedCrossRef
28.
Zurück zum Zitat Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg. 2003;185:538–43.PubMedCrossRef Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg. 2003;185:538–43.PubMedCrossRef
29.
Zurück zum Zitat Lee HK, Vaporciyan AA, Cox JD, et al. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters. Int J Radiat Oncol Biol Phys. 2003;57:1317–22.PubMedCrossRef Lee HK, Vaporciyan AA, Cox JD, et al. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters. Int J Radiat Oncol Biol Phys. 2003;57:1317–22.PubMedCrossRef
30.
Zurück zum Zitat Kaklamanos IG, Walker GR, Ferry K, Franceschi D, Livingstone AS. Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol. 2003;10:754–61.PubMedCrossRef Kaklamanos IG, Walker GR, Ferry K, Franceschi D, Livingstone AS. Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol. 2003;10:754–61.PubMedCrossRef
31.
Zurück zum Zitat Zane Atkins B, Shah AS, Hutcheson KA, et al. Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg. 2004;78:1170–6.PubMedCrossRef Zane Atkins B, Shah AS, Hutcheson KA, et al. Reducing hospital morbidity and mortality following esophagectomy. Ann Thorac Surg. 2004;78:1170–6.PubMedCrossRef
32.
Zurück zum Zitat Blewett CJ, Miller JD, Young EM, Bennett WF, Urschel JD. Anastomotic leaks after esophagectomy for esophageal cancer: a comparison of thoracic and cervical anastomoses. Ann Thorac Cardiovasc Surg. 2001;7:75–8.PubMed Blewett CJ, Miller JD, Young EM, Bennett WF, Urschel JD. Anastomotic leaks after esophagectomy for esophageal cancer: a comparison of thoracic and cervical anastomoses. Ann Thorac Cardiovasc Surg. 2001;7:75–8.PubMed
Metadaten
Titel
Factors Associated with Postoperative Pulmonary Morbidity After Esophagectomy for Cancer
Publikationsdatum
01.05.2011
Erschienen in
Annals of Surgical Oncology / Ausgabe 5/2011
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1474-5

Weitere Artikel der Ausgabe 5/2011

Annals of Surgical Oncology 5/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.